DP
LMAT icon

Dundas Partners’s LeMaitre Vascular LMAT Stock Holding History

Dundas Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,920
Closed -$210K – 41
2026
Q1 		$210K Sell
1,920
-1,326
-41% -$126K 0.02% 43
2025
Q4 		$263K Buy
3,246
+586
+22% +$50.4K 0.02% 46
2025
Q3 		$233K Hold
2,660
– – 0.02% 48
2025
Q2 		$221K Buy
+2,660
New +$222K 0.02% 47

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dundas Partners's LMAT Position: Q2 2026 in Review

Dundas Partners sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 1,920 shares — an estimated $210K sold.

Dundas Partners first reported a position in LMAT in Q2 2025 and held it in 4 quarters. The position peaked at $263K in Q4 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Dundas Partners reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Dundas Partners sold 1,920 LeMaitre Vascular shares in Q2 2026, an estimated $210K.
  • Dundas Partners first reported a position in LeMaitre Vascular in Q2 2025 and held it in 4 quarters.
  • Dundas Partners's LeMaitre Vascular position peaked at $263K in Q4 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Dundas Partners's 13F filing for Q2 2026, filed 14 Aug 2026.